Vontobel Holding’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Sell |
45,356
-3,013
| -6% | -$15.2K | ﹤0.01% | 1002 |
|
|
2025
Q1 | $313K | Sell |
48,369
-6,872
| -12% | -$44.5K | ﹤0.01% | 900 |
|
|
2024
Q4 | $405K | Sell |
55,241
-2,205
| -4% | -$16.2K | ﹤0.01% | 843 |
|
|
2024
Q3 | $430K | Buy |
57,446
+12,511
| +28% | +$93.7K | ﹤0.01% | 824 |
|
|
2024
Q2 | $400K | Sell |
44,935
-1,974
| -4% | -$17.6K | ﹤0.01% | 836 |
|
|
2024
Q1 | $475K | Sell |
46,909
-690
| -1% | -$6.99K | ﹤0.01% | 797 |
|
|
2023
Q4 | $479K | Sell |
47,599
-3,220
| -6% | -$32.4K | ﹤0.01% | 809 |
|
|
2023
Q3 | $476K | Buy |
50,819
+24,656
| +94% | +$231K | ﹤0.01% | 786 |
|
|
2023
Q2 | $642K | Sell |
26,163
-2,087
| -7% | -$51.2K | 0.01% | 728 |
|
|
2023
Q1 | $657K | Sell |
28,250
-4,264
| -13% | -$99.2K | 0.01% | 714 |
|
|
2022
Q4 | $823K | Sell |
32,514
-6,066
| -16% | -$154K | 0.01% | 625 |
|
|
2022
Q3 | $744K | Buy |
38,580
+1,436
| +4% | +$27.7K | 0.01% | 612 |
|
|
2022
Q2 | $966K | Sell |
37,144
-6,391
| -15% | -$166K | 0.01% | 549 |
|
|
2022
Q1 | $1.13M | Buy |
43,535
+12,499
| +40% | +$324K | 0.01% | 582 |
|
|
2021
Q4 | $1.26M | Sell |
31,036
-1,250
| -4% | -$50.8K | 0.01% | 568 |
|
|
2021
Q3 | $1.41M | Buy |
32,286
+7,595
| +31% | +$331K | 0.01% | 535 |
|
|
2021
Q2 | $1.17M | Sell |
24,691
-1,715
| -6% | -$81.1K | 0.01% | 559 |
|
|
2021
Q1 | $1.35M | Sell |
26,406
-16,305
| -38% | -$836K | 0.01% | 477 |
|
|
2020
Q4 | $1.14M | Buy |
+42,711
| New | +$1.14M | 0.01% | 472 |
|